NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Newsletters
Advertisement
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
HONcode
Security by Verisign

Drug Week


Susan Hasty, Publisher
Table of Contents . . . March 31st, 2000
Non-Subscriber - Summaries Only
Related Areas: Other Issues in Drug Week | Other Publications

Platelet Inhibitor Therapy - Heart Drug Cuts Death and Heart Attack Rate By 40% in Angioplasty-Stent Procedure

Alzheimer's Disease - Eptastigmine Improves Cognitive Performance and Global Functioning

Analgesia - Fentanyl Increases Delayed Pain Sensitivity

Congestive Heart Failure - Toprol-XL Reduces Hospitalizations, Increases Survival

Drug Resistance - Study Clarifies Definition of Anthracycline Resistance

Gender Studies - Pain Drug Reveals What Most Already Know: Men's and Women's Brains Are Simply Different

Juvenile Rheumatoid Arthritis - Etanercept a "Dramatic Advancement" in Treatment, Say Researchers

Malaria - Structure of Malaria Pigment Revealed

Osteoarthritis - Glucosamine and Chondroitin Supplements Might Help

Pertussis - Vaccine Induces Specific Mucosal Antibody Responses in Humans

Rheumatoid Arthritis - New Drugs Offer Pain Relief without NSAID Side Effects

Stable Angina - Nifedipine GITS Effective in Heart Disease Patients

Whiplash - Botulinum Toxin-A Injection Improves Range of Motion

Adverse Drug Effects - Study: High Number of Deaths and Cardiovascular Events Associated with Viagra

Allergy Medicine - Phase I Results for Ragweed Immunotherapy Presented

Alzheimer's Disease - Aricept Improves Cognition/Global Function in Nursing Home Patients

Asthma - Monoclonal Antibody Reduces Frequency of Asthma Exacerbations

Asthma - New Findings on Immune System Control of Eosinophils Presented

Cefaclor - Role of Reactive Metabolites in Serum Sickness-Like Reactions

Eczema - Steroid-Free Medications Might Offer Alternative Treatment Option

HIV Gene Therapy - WF10 Modifies Cytokine Gene Expression

HIV Immunotherapy - Investigational HIV Therapy Targets Immune Stimulation

Hypertension - Drug Rapidly Improves Blood Vessel Dilation and Flow in Hypercholesterolemic Patients

Immunosuppression - Hormone Has Potential Use in Autoimmunity and Transplantation

Limb Ischemia - Trials Announced for Treatment without Amputation

Migraine - Prophylactic Dotarizine Helps Reduce Headaches

Platelet Inhibitor Therapy - Tailored Use May Prevent Second Heart Attacks

Therapy - Docetaxel-Vinorelbine Combination Successful in Metastatic Breast Cancer Patients

Vaccine Adjuvants - Saponin QS-21 Has Potential as Mucosal Adjuvant

Adverse Drug Events - Diabetes Drug Controversy Mounts

Drug Development - Leading Pharmaceutical Companies to Quadruple Number of New Medicines Launched Annually

Drug Safety - FDA Mulls Diabetes Drug Disclosure

Industry News - FDA Approves Zyprexa for Bipolar Disorder Symptom

Leukemia - FDA Panel Verdict Mixed on Cancer Drug

Migraine - Nasal Spray Approval Sought for Adolescents

Scleroderma - Collagen Synthesis Inhibitor Receives Orphan Drug Designation

Small Cell Lung Cancer - Orphan Drug Designation Received for Radiation Therapy Product

Traumatic Brain Injury - Successful Completion of Phase II Head Trauma Clinical Studies Announced



Return to Top of Page

-----------------------
PR Login